Applied Molecular Transport to Present at BofA Securities 2022 Healthcare Conference

Rhea-AI Summary

Applied Molecular Transport Inc. (Nasdaq: AMTI) will have its CEO, Tahir Mahmood, participate in a fireside chat at the BofA Securities 2022 Healthcare Conference on May 10, 2022, at 2:20 p.m. ET. The event will be streamed live on their website, with an archived replay available for 30 days post-event. AMT is a clinical-stage biopharmaceutical company focused on developing oral biologic product candidates aimed at treating autoimmune, inflammatory, and metabolic diseases. Their technology enables precise targeting of therapeutic modalities across the intestinal epithelium.

SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the BofA Securities 2022 Healthcare Conference in Las Vegas on Tuesday, May 10, 2022 at 2:20 p.m. ET (11:20 a.m. PT).

A live webcast will be accessible via the Events page of the Applied Molecular Transport website at https://ir.appliedmt.com/news-events/events. An archived replay will be available for 30 days following the event.

About Applied Molecular Transport Inc.

AMT is a clinical-stage biopharmaceutical company developing novel oral biologic product candidates, by leveraging its technology platform to design and advance a multi-product pipeline to treat autoimmune, inflammatory, metabolic and other diseases. AMT is developing its oral biologic product candidates in patient-friendly oral dosage forms that are designed to either target local intestinal tissue or enter systemic circulation to precisely address the relevant pathophysiology of disease. AMT’s proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of diverse therapeutic modalities across the IE barrier. Active transport is an efficient mechanism that uses the cell’s own machinery to transport materials across the IE barrier.

AMT’s headquarters, internal GMP manufacturing and lab facilities are located in South San Francisco, CA. For additional information on AMT, please visit www.appliedmt.com. 

Investor Relations Contact:
Andrew Chang
Head, Investor Relations & Corporate Communications
achang@appliedmt.com

Media Contacts:
Alexandra Santos
Wheelhouse Life Science Advisors
asantos@wheelhouselsa.com

Aljanae Reynolds
Wheelhouse Life Science Advisors
areynolds@wheelhouselsa.com

FAQ

When is Tahir Mahmood participating in the BofA Securities 2022 Healthcare Conference?

Tahir Mahmood will participate in the conference on May 10, 2022, at 2:20 p.m. ET.

Where can I watch the fireside chat of AMTI's CEO?

The fireside chat can be viewed live on the Applied Molecular Transport website on their Events page.

What is Applied Molecular Transport Inc. known for?

AMTI is known for developing oral biologic product candidates for treating autoimmune and metabolic diseases.

What type of company is AMTI?

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company.

How can I access the archived replay of the event?

The archived replay of the fireside chat will be available for 30 days following the event on AMTI's website.